Recombinant vaccinia viruses expressing GP46/M-2 protect against Leishmania infection
about
The evolution of poxvirus vaccinesHuman and murine immune responses to a novel Leishmania major recombinant protein encoded by members of a multicopy gene family.A novel Leishmania infantum recombinant antigen which elicits interleukin 10 production by peripheral blood mononuclear cells of patients with visceral leishmaniasis.Mapping the antigenicity of the parasites in Leishmania donovani infection by proteome serologyBiochemical and biological characterization of the protective Leishmania pifanoi amastigote antigen P-8.In vitro evaluation of a soluble Leishmania promastigote surface antigen as a potential vaccine candidate against human leishmaniasisLeishmaniasis: current status of vaccine developmentSubunit vaccination of mice against new world cutaneous leishmaniasis: comparison of three proteins expressed in amastigotes and six adjuvants.Protection against cutaneous leishmaniasis induced by recombinant antigens in murine and nonhuman primate models of the human disease.Immunization with a polyprotein vaccine consisting of the T-Cell antigens thiol-specific antioxidant, Leishmania major stress-inducible protein 1, and Leishmania elongation initiation factor protects against leishmaniasis.Perforin and gamma interferon are critical CD8+ T-cell-mediated responses in vaccine-induced immunity against Leishmania amazonensis infection.Evaluation of Toxoplasma gondii as a live vaccine vector in susceptible and resistant hosts.Leishmania pifanoi amastigote antigens protect mice against cutaneous leishmaniasis.Protective vaccination with promastigote surface antigen 2 from Leishmania major is mediated by a TH1 type of immune responseMyd88-dependent in vivo maturation of splenic dendritic cells induced by Leishmania donovani and other Leishmania species.Leishmania-reactive CD4+ and CD8+ T cells associated with cure of human cutaneous leishmaniasis.Attenuated and replication-competent vaccinia virus strains M65 and M101 with distinct biology and immunogenicity as potential vaccine candidates against pathogens.Proteoliposomes in nanobiotechnology.Vaccination of BALB/c mice with Leishmania major amastigote-specific cysteine proteinase
P2860
Q26995905-F06CE64B-30FA-4DEA-81EA-C00D09D4406DQ28585935-D07E3810-82D0-4D22-97B1-8DCA52FBC559Q30833358-8C2877AE-E960-4628-A311-4C456FFE9CCDQ33267301-094ADED5-9360-4890-926C-CA7E7373D6D6Q33552567-EB47C535-A6A0-4128-8C94-03DE2B63D6FEQ33559668-932BFD32-2749-4E0B-A7EF-5B040CBD0767Q33941719-EB231A84-D44B-4BA6-8753-E782FA0BB53FQ34003547-53226352-7A1C-447C-8D2A-863189CBA333Q34008104-C631C7F5-443C-431A-8970-2042AED76F4DQ34128082-E01C3818-C7EA-42A3-988C-1823A714AB94Q35011520-50FB5BA3-D66E-41D3-9D92-ED83BAD073D6Q35225633-E48693F7-27D0-4FE4-8AEA-95E823E4A66AQ35437937-D7DE7D92-F3A5-447D-8A9E-D8F4FDECCA52Q35448239-FC306F30-839A-4C5E-B115-8B80139643FDQ35550430-5B5E8A22-A2C1-4C65-AA48-41C6899EABD1Q35783219-F4D13D16-BC4F-4FC4-9171-8A2D55C927A9Q36911682-F20DD871-5BE3-46A6-8271-BE209AC154BFQ39310225-77B935ED-E4E8-4EDA-BCCC-DC54D45FC5C5Q57954572-44ADCF6D-8B93-41B9-AF70-86C2FB65145B
P2860
Recombinant vaccinia viruses expressing GP46/M-2 protect against Leishmania infection
description
1993 nî lūn-bûn
@nan
1993 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Recombinant vaccinia viruses expressing GP46/M-2 protect against Leishmania infection
@ast
Recombinant vaccinia viruses expressing GP46/M-2 protect against Leishmania infection
@en
type
label
Recombinant vaccinia viruses expressing GP46/M-2 protect against Leishmania infection
@ast
Recombinant vaccinia viruses expressing GP46/M-2 protect against Leishmania infection
@en
prefLabel
Recombinant vaccinia viruses expressing GP46/M-2 protect against Leishmania infection
@ast
Recombinant vaccinia viruses expressing GP46/M-2 protect against Leishmania infection
@en
P2093
P2860
P1476
Recombinant vaccinia viruses expressing GP46/M-2 protect against Leishmania infection
@en
P2093
D McMahon-Pratt
D Rodriguez
J F Rodriguez
J R Rodriguez
K L Lohman
N H Ruddle
P2860
P304
P407
P577
1993-08-01T00:00:00Z